Effect of PPM1F in dorsal raphe 5-HT neurons in regulating methamphetamine-induced conditioned place preference

Yong Liu1, Min Wu2, Zongyue Sun3

  • 1Department of Physiology, Binzhou Medical University, Shandong, China; Medical research center, Binzhou Medical University Hospital, Binzhou, Shandong, China; Institute for Metabolic & Neuropsychiatric Disorders, Binzhou Medical University Hospital, Binzhou, Shandong, China.

Brain Research Bulletin
|December 6, 2021
PubMed

Insights

Protein phosphatase PPM1F in the brain

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Methamphetamine (METH) is a highly addictive stimulant.
  • The role of Protein phosphatase Mg2+/Mn2+-dependent 1F (PPM1F) in METH addiction is unknown.
  • PPM1F has diverse biological functions.

Purpose of the Study:

  • To investigate the role of PPM1F in METH addiction.
  • To explore PPM1F's neuronal substrates and their involvement in METH-induced behaviors.

Main Methods:

  • Established a METH-induced conditioned place preference (CPP) mouse model.
  • Utilized adeno-associated virus (AAV) for PPM1F knockout and overexpression in the dorsal raphe nucleus (DRN).
  • Analyzed expression levels of PPM1F, TPH2, SERT, and 5-HT in mouse brains and blood samples.

Main Results:

  • METH treatment decreased PPM1F expression in DRN 5-HT neurons, correlating with addiction severity.
  • PPM1F knockout in DRN enhanced METH CPP, while overexpression attenuated it.
  • PPM1F deficiency led to reduced TPH2, SERT, and 5-HT levels in the DRN.
  • Lower PPM1F levels were observed in METH abusers' blood.

Conclusions:

  • PPM1F in DRN 5-HT neurons modulates METH-induced CPP.
  • PPM1F influences the 5-HT neurotransmitter system.
  • PPM1F may serve as a biomarker and therapeutic target for METH addiction.

Related Concept Videos